HealthCor Management’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | $2.39M | Sell |
|
|||||
|
2022
Q3 | $2.31M | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $2.2M | Sell |
|
|||||
|
2021
Q4 | $31.1M | Sell |
|
|||||
|
2021
Q3 | $42.8M | Buy |
|
|||||
|
2021
Q2 | $38M | Buy |
|
|||||
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $21.7M | Sell |
|
|||||
|
2020
Q3 | $89.1M | Buy |
|
|||||
|
2020
Q2 | $43.4M | Sell |
|
|||||
|
2020
Q1 | $134M | Buy |
|
|||||
|
2019
Q4 | $86.7M | Sell |
|
|||||
|
2019
Q3 | $135M | Sell |
|
|||||
|
2019
Q2 | $200M | Buy |
|
|||||
|
2019
Q1 | $134M | Buy |
|
|||||
|
2018
Q4 | $54.9M | Buy |
|
|||||
|
2018
Q3 | $50.5M | Sell |
|
|||||
|
2018
Q2 | $78M | Buy |
|
|||||
|
2018
Q1 | $57.4M | Sell |
|
|||||
|
2017
Q4 | $118M | Sell |
|
|||||
|
2017
Q3 | $128M | Sell |
|
|||||
|
2017
Q2 | $117M | Buy |
|
|||||
|
2017
Q1 | $53M | Buy |
|
|||||
|
2016
Q4 | $38.3M | Buy |
|
|||||
|
2016
Q3 | – | Sell |
|
|||||
|
2016
Q2 | $20.5M | Sell |
|
|||||
|
2016
Q1 | $28.7M | Buy |
|
|||||
|
2015
Q4 | – | Sell |
|
|||||
|
2015
Q3 | $5.97M | Buy |
|